Biotech industry faces funding challenges and layoffs in 2024, while big pharma pursues acquisitions. Ikena cuts half of workforce
Companies across the industry have contributed to biotech layoffs in early 2024, driven by factors ranging from operational restructuring to strategic pivots and. Nbi stock index remains volatile in q1.
Is There Room For Optimism?
Already more than half a dozen biotech companies have announced layoffs, and venture investors have signaled changes in how they plan to build new startups.
Takeda Plans 641 More Layoffs;
More recently, two months after acquiring san diego biotech mirati therapeutics in january 2024, in a deal worth $4.8 billion, bristol myers squibb said in a.
Images References :
There Were 57 Layoffs Reported For The First 3 Months Of 2024โThe Exact Number Reported During Q1 Last Year, According To A Fierce Biotech Analysis.
Securing top talent in research and development and manufacturing will remain challenging for life sciences companies in 2024, according to a new report by.